داروسازی کوثر
دکوثر | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
-
Last Price: - 0.00
Close Price: -
Balance Sheet
AGM
Interim
2026/04/26 Fiscal Year 2025/12/2112 Month | 2025/08/06 Fiscal Year 2025/03/2012 Month | 2024/07/07 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Cash & Bank Balances | 1.286 Trillion | 606.779 Billion | 599.565 Billion | |
Trade Receivables | 9.153 Trillion | 11.196 Trillion | 7.358 Trillion | |
Prepayments | 606.953 Billion | 421.186 Billion | 980.627 Billion | |
Raw Materials & Packaging Inventory | 2.082 Trillion | 3.107 Trillion | 2.267 Trillion | |
Work-in-Progress Inventory | 696.312 Billion | 937.3 Billion | 512.074 Billion | |
Finished Goods Inventory | 1.3 Trillion | 173.204 Billion | 29.757 Billion | |
Spare Parts Inventory | 84.614 Billion | 73.252 Billion | 35.5 Billion | |
Goods in Transit | 331.264 Billion | 427.092 Billion | 752.446 Billion | |
Our Goods on Consignment with Others | 6.618 Billion | 54.982 Billion | - | |
Other Inventories | - | - | 567.844 Billion | |
Inventories | 4.501 Trillion | 4.772 Trillion | 4.164 Trillion | |
Total Current Assets | 15.546 Trillion | 16.996 Trillion | 13.103 Trillion | |
Long-Term Investments | 435 Million | 371.303 Billion | 242.463 Billion | |
Long-Term Investments in Affiliates | 402.316 Billion | - | - | |
Intangible Assets | 21.964 Billion | 36.024 Billion | 30.744 Billion | |
Property, Plant & Equipment | 7.845 Trillion | 1.079 Trillion | 1.039 Trillion | |
Net Fixed Assets | 7.845 Trillion | 1.079 Trillion | 1.039 Trillion | |
Total Non-Current Assets | 8.27 Trillion | 1.486 Trillion | 1.312 Trillion | |
Total Assets | 23.816 Trillion | 18.482 Trillion | 14.415 Trillion | |
Trade Payables | 3.133 Trillion | 3.542 Trillion | 2.607 Trillion | |
Advances Received | 2.156 Trillion | 655.793 Billion | 152.523 Billion | |
Income Tax Provision | 539.378 Billion | 435.796 Billion | 461.533 Billion | |
Other Provisions | 249.111 Billion | 310.017 Billion | 645.134 Billion | |
Proposed & Payable Dividends | 110.799 Billion | 159.979 Billion | 230.611 Billion | |
Current Borrowings | 4.131 Trillion | 7.005 Trillion | 4.88 Trillion | |
Total Current Liabilities | 10.32 Trillion | 12.109 Trillion | 8.977 Trillion | |
Long-Term Borrowings | 1.5 Trillion | 1.5 Trillion | - | |
Employee Termination Benefits Provision | 297.767 Billion | 205.437 Billion | 118.061 Billion | |
Total Non-Current Liabilities | 2.132 Trillion | 1.705 Trillion | 118.061 Billion | |
Total Liabilities | 12.451 Trillion | 13.814 Trillion | 9.095 Trillion | |
Capital | 3.4 Trillion | 1.7 Trillion | 1.7 Trillion | |
Retained Earnings | 1.271 Trillion | 2.798 Trillion | 3.45 Trillion | |
Legal Reserve | 222.191 Billion | 170 Billion | 170 Billion | |
Total Equity | 11.365 Trillion | 4.668 Trillion | 5.32 Trillion | |
Total Liabilities & Equity | 23.816 Trillion | 18.482 Trillion | 14.415 Trillion | |
Approved Capital | 3.4 Trillion | 1.7 Trillion | 1.7 Trillion | |
Approved Retained Earnings | 1.165 Trillion | 2.759 Trillion | 3.256 Trillion | |
Approved Legal Reserve | 222.191 Billion | 170 Billion | 170 Billion | |
Total Approved Equity (at AGM) | 4.788 Trillion | 4.629 Trillion | 5.126 Trillion | |
Revaluation Surplus of Property, Plant and Equipment | 6.472 Trillion | - | - | |
درآمد انتقالی به دورههای آتی | 333.906 Billion | - | - |
